325 related articles for article (PubMed ID: 36420875)
1. Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design.
Maleksabet H; Rezaee E; Tabatabai SA
Curr Pharm Des; 2022; 28(45):3583-3591. PubMed ID: 36420875
[TBL] [Abstract][Full Text] [Related]
2. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.
Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS
J Biol Chem; 2021; 296():100759. PubMed ID: 33965375
[TBL] [Abstract][Full Text] [Related]
3. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Gadanec LK; McSweeney KR; Qaradakhi T; Ali B; Zulli A; Apostolopoulos V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498183
[TBL] [Abstract][Full Text] [Related]
4. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
[TBL] [Abstract][Full Text] [Related]
5. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
7. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
8. ACE2-independent SARS-CoV-2 virus entry through cell surface GRP78 on monocytes - evidence from a translational clinical and experimental approach.
Han B; Lv Y; Moser D; Zhou X; Woehrle T; Han L; Osterman A; Rudelius M; Choukér A; Lei P
EBioMedicine; 2023 Dec; 98():104869. PubMed ID: 37967509
[TBL] [Abstract][Full Text] [Related]
9. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 cell entry beyond the ACE2 receptor.
Alipoor SD; Mirsaeidi M
Mol Biol Rep; 2022 Nov; 49(11):10715-10727. PubMed ID: 35754059
[TBL] [Abstract][Full Text] [Related]
11. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.
Liu Y; Hu G; Wang Y; Ren W; Zhao X; Ji F; Zhu Y; Feng F; Gong M; Ju X; Zhu Y; Cai X; Lan J; Guo J; Xie M; Dong L; Zhu Z; Na J; Wu J; Lan X; Xie Y; Wang X; Yuan Z; Zhang R; Ding Q
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33658332
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns.
Dong L; Pei S; Ren Q; Fu S; Yu L; Chen H; Chen X; Yin M
Placenta; 2021 Aug; 111():91-96. PubMed ID: 34217121
[TBL] [Abstract][Full Text] [Related]
14. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
[TBL] [Abstract][Full Text] [Related]
15. Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2.
Ojha R; Gurjar K; Ratnakar TS; Mishra A; Prajapati VK
Hum Immunol; 2022 Apr; 83(4):346-355. PubMed ID: 35042653
[TBL] [Abstract][Full Text] [Related]
16. Effect of Cysteine Oxidation in SARS-CoV-2 Receptor-Binding Domain on Its Interaction with Two Cell Receptors: Insights from Atomistic Simulations.
Ghasemitarei M; Privat-Maldonado A; Yusupov M; Rahnama S; Bogaerts A; Ejtehadi MR
J Chem Inf Model; 2022 Jan; 62(1):129-141. PubMed ID: 34965734
[TBL] [Abstract][Full Text] [Related]
17. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
[TBL] [Abstract][Full Text] [Related]
18. Human cell receptors: potential drug targets to combat COVID-19.
Raghav PK; Kalyanaraman K; Kumar D
Amino Acids; 2021 Jun; 53(6):813-842. PubMed ID: 33950300
[TBL] [Abstract][Full Text] [Related]
19. Metainflammation in COVID-19.
Bakhtiari M; Asadipooya K
Endocr Metab Immune Disord Drug Targets; 2022; 22(12):1154-1166. PubMed ID: 34983356
[TBL] [Abstract][Full Text] [Related]
20. Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface.
Lazou M; Hutton JR; Chakravarty A; Joseph-McCarthy D
J Comput Aided Mol Des; 2024 Jan; 38(1):6. PubMed ID: 38263499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
